← Назад к работе
Работы, на которые ссылается эта работа
Работ: 23
Работа: Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan
Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis
Mayara Lisboa Bastos, Hamidah Hussain, Karin Weyer +82
Обзорная статья2014Цитирований: 4ABICounting Pyrazinamide in Regimens for Multidrug-Resistant Tuberculosis
Molly F. Franke, Mercedes C. Becerra, Dylan B. Tierney +5
Статья2015Цитирований: 3ABIPyrazinamide May Improve Fluoroquinolone-Based Treatment of Multidrug-Resistant Tuberculosis
Kwok Chiu Chang, Chi Chiu Leung, Wing‐Wai Yew +4
Статья2012Цитирований: 2ABIEfficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis
Rodney Dawson, Andreas H. Diacon, Daniel E. Everitt +16
Статья2015Цитирований: 2ABIA Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis
Michael G. Whitfield, Heidi M. Soeters, Robin M. Warren +5
Обзорная статья2015Цитирований: 2ABI